Table 2.
|
Injection sites |
||||
---|---|---|---|---|---|
Areas |
M1 (n = 3) |
PMd (n = 2) |
PMv (n = 2) |
||
Lateral surface | |||||
M1 | - | 28.8 | 18.4 | ||
PMd | 23.0 | - | 9.8 | ||
PMv | 20.1 | 18.1 | - | ||
Subtotal | 43.1 | 46.9 | 28.1 | ||
Medial wall | |||||
SMA | 9.5 | 21.3 | 14.1 | ||
CMAd | 5.2 | 4.4 | 1.5 | ||
CMAv | 1.9 | 1.3 | 1.9 | ||
CMAr | 0.2 | 0.8 | 1.5 | ||
Subtotal | 16.8 | 27.8 | 19.0 | ||
Prefrontal | |||||
Pre-SMA | 0 | 0 | 0 | ||
Pre-PMd | 0.1 | 0.3 | 0 | ||
PrCO | 0.5 | 0.1 | 8.5 | ||
46d | 0.1 | 0.3 | 0.3 | ||
46v | 0.1 | 0.1 | 4.1 | ||
12l | 0 | 0 | 0.4 | ||
12o | 0 | 0 | 0.2 | ||
Subtotal | 0.8 | 0.8 | 13.5 | ||
Parietal | |||||
Subtotal | 39.3 | 24.3 | 39.3 | ||
Total number of labeled cells |
54,712 |
49,395 |
71,560 |